Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Exscientia Ltd ADR (EXAI)

Exscientia Ltd ADR (EXAI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.84 +0.15 (+3.20%) 11/19/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.84 unch (unch) -
News & Headlines for Tue, Nov 19th, 2024
NVIDIA Invested in These 2 AI Stocks, Should You?

Discover 2 compelling AI stocks NVIDIA (NASDAQ: NVDA) has invested in. Learn how the AI leader's vision can guide your portfolio in the tech revolution.

SERV : 5.22 (-3.51%)
NVDA : 94.31 (-7.36%)
OUST : 7.20 (-11.00%)
MGA : 32.47 (-1.99%)
SHAK : 78.56 (-6.71%)
RXRX : 4.24 (-11.85%)
EXAI : 4.84 (+3.20%)
RHHBY : 37.6500 (-5.92%)
CMG : 47.29 (-5.57%)
UBER : 64.62 (-7.49%)
SNY : 51.98 (-4.83%)
Inside the AI-Healthcare Boom: Breakthroughs in Diagnostics and Personalized Treatment

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems...

MSFT : 359.84 (-3.56%)
NVDA : 94.31 (-7.36%)
TWST : 36.19 (-3.49%)
AVAI : 0.4100 (+0.74%)
ABSI : 2.28 (+2.01%)
RXRX : 4.24 (-11.85%)
EXAI : 4.84 (+3.20%)
1 AI Biotech Stock That Just Scored a Major Milestone

Down over 85% from all-time highs, Recursion Pharmaceuticals is an AI-powered biotech company that aims to accelerate the drug discovery process.

BAYZF : 22.0000 (-7.21%)
RXRX : 4.24 (-11.85%)
EXAI : 4.84 (+3.20%)
SNY : 51.98 (-4.83%)
AI in Healthcare Set for Explosive Growth with Projections Hitting $613 Billion by 2034

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Health care is undergoing a tech revolution, with health systems increasingly leveraging artificial intelligence (AI)...

BLFY : 8.87 (+0.68%)
AVAI : 0.4100 (+0.74%)
GEHC : 60.51 (-15.96%)
RXRX : 4.24 (-11.85%)
EXAI : 4.84 (+3.20%)
AI Revolution in Healthcare Gains Momentum as FDA Prepares for Tech Boom

/CNW/ -- USA News Group – Health care is undergoing a tech revolution, with health systems increasingly leveraging artificial intelligence (AI) bots for...

BLFY : 8.87 (+0.68%)
AVAI : 0.4100 (+0.74%)
GEHC : 60.51 (-15.96%)
RXRX : 4.24 (-11.85%)
EXAI : 4.84 (+3.20%)
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why.

Merging with a former rival will bolster its capabilities.

NVDA : 94.31 (-7.36%)
RXRX : 4.24 (-11.85%)
EXAI : 4.84 (+3.20%)
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:EXAI),(NASDAQ:TWST),(NYSE:IQV) EQNX::TICKER_END

AVAI : 0.4100 (+0.74%)
RXRX : 4.24 (-11.85%)
EXAI : 4.84 (+3.20%)
TWST : 36.19 (-3.49%)
IQV : 154.73 (-7.73%)
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

AVAI : 0.4100 (+0.74%)
RXRX : 4.24 (-11.85%)
EXAI : 4.84 (+3.20%)
TWST : 36.19 (-3.49%)
IQV : 154.73 (-7.73%)
Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia?

The leading company pioneering artificial intelligence (AI)-fueled drug discovery could get much bigger.

EXAI : 4.84 (+3.20%)
RXRX : 4.24 (-11.85%)
3 Small-Cap Stocks to Invest in AI Drug Development

As AI continues to reshape the drug development landscape, here are three promising small-cap biotech stocks worth considering now.

RXRX : 4.24 (-11.85%)
SDGR : 18.03 (-4.45%)
EXAI : 4.84 (+3.20%)
NVDA : 94.31 (-7.36%)

Barchart Exclusives

Should You Buy the Dip in Apple Stock in April 2025?
Here is what you should do as Apple falls 22% from its 52-week high. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades